On (b)(6) 2016 the reporter contacted animas alleging that on an unspecified date, the patient experienced elevated blood glucose (bg) up to 350mg/dl with blurred vision, nausea, thirst, and light headedness.Reportedly, the patient did not receive any treatment above and beyond the usual routine of diabetes care and management and remained on the pump.The reporter stated that the patient was under increased stress but was unwilling to rule out the pump; the reporter alleged that the patient did not feel the pump was delivering insulin accurately.The reporter noted that the patient's uncle had died, the patient's aunt was on life support, and the patient's spouse was in the emergency room.Additionally, the reporter noted that the patient had a history of multiple previous strokes.This complaint is being reported based on the allegation that the patient experienced hyperglycemia associated with alleged insulin delivery issue.
|
Follow-up #1: date of submission 07/12/2006.Device evaluation: the device has been returned and evaluated by product analysis on 06/29/2016 with the following findings: a review of the black box indicated that the last basal and last bolus deliveries occurred on (b)(6) 2016.The black box showed an occlusion alarm at 23:53 on (b)(6) 2016 and deliveries resumed on (b)(6) 2016 at 05:43.A review of the total daily dose history indicated that insulin delivery totals correctly reflected programmed values.The pump successfully completed a rewind, load, and prime sequence.The pump was exercised for 24 hours with no errors, alarms, or warnings occurring.A 10 unit audio bolus and a 10 unit normal bolus were successfully completed with no issues.The pump passed delivery accuracy testing and was found to be delivering within required specifications.The complaint could not be confirmed or duplicated on investigation.Animas has conducted a review of the device history record for this pump and confirmed that it was operating within required specifications at the time of release.
|